Testing effectiveness (Phase 2)Ended earlyNCT00230334What this trial is testingPhase II Gleevec Idiopathic Hypereosinophilic SyndromeWho this might be right forEosinophiliaHypereosinophilic Syndrome Steven E. Coutre 5
Not applicableStudy completedNCT05063981What this trial is testingTreatment With Mepolizumab on Patients With Severe Refractory Eosinophilic AsthmaWho this might be right forSevere Eosinophilic Asthma Istituti Clinici Scientifici Maugeri SpA 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT03862157What this trial is testingAzacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaWho this might be right forAcute Myeloid LeukemiaAtypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeChronic Eosinophilic Leukemia, Not Otherwise Specified+13 more M.D. Anderson Cancer Center 40
Not applicableUnknownNCT04933344What this trial is testingPharmacokinetics and Toxicodynamics of Daptomycin in Bone and Joint InfectionsWho this might be right forDactinomycin Adverse ReactionBone and Joint Infection Hospices Civils de Lyon 1,130
Testing effectiveness (Phase 2)UnknownNCT02101138What this trial is testingStudy to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic SyndromeWho this might be right forHypereosinophilic Syndrome National Institute of Allergy and Infectious Diseases (NIAID) 15
Testing effectiveness (Phase 2)Study completedNCT03683576What this trial is testingGB001 in Adult Subjects With Moderate to Severe AsthmaWho this might be right forAsthma GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc. 481
Not applicableStudy completedNCT01713504What this trial is testingIdentification of New Markers in the Hypereosinophilic SyndromeWho this might be right forHypereosinophilic Syndrome University Hospital, Lille 41
Post-approval studies (Phase 4)Looking for participantsNCT04565483What this trial is testingPredictive Signature of Benralizumab ResponseWho this might be right forAsthma; EosinophilicSevere Asthma Nantes University Hospital 220
Not applicableUnknownNCT04641741What this trial is testingEffect of Mepolizumab on Severe Eosinophilic AsthmaWho this might be right forAsthmaEosinophilic Asthma Hospital Clinico Universitario de Santiago 30
Post-approval studies (Phase 4)UnknownNCT04228588What this trial is testingA Pragmatic Study to Investigate the Efficacy and Safety of Mepolizumab in Severe Uncontrolled Asthma in BrazilWho this might be right forEosinophilic Asthma University of Sao Paulo General Hospital 18
Not applicableEnded earlyNCT06302959What this trial is testingClock Proteins as Prognostic MarkersWho this might be right forSevere Eosinophilic Asthma Medical University of Graz 50
Not applicableUnknownNCT03739320What this trial is testingA Study on the Effect of Mepolizumab Therapy on Daily Physical Activity of Patients With Severe Eosinophilic AsthmaWho this might be right forSevere Eosinophilic Asthma Sotiria General Hospital 50
Large-scale testing (Phase 3)Ended earlyNCT01290887What this trial is testingOpen-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0 mg/kg) as Treatment for Patients (12 Through 75 Years of Age) With Eosinophilic AsthmaWho this might be right forEosinophilic Asthma Teva Branded Pharmaceutical Products R&D, Inc. 1,052
Not applicableStudy completedNCT02581514What this trial is testingEosinophilia DiagnosisWho this might be right forHypereosinophilic Syndrome University Hospital, Limoges 53
Large-scale testing (Phase 3)Ended earlyNCT00097370What this trial is testingOpen-Label Extension Of Intravenous Mepolizumab In Patients With Hypereosinophilic SyndromeWho this might be right forHypereosinophilic Syndrome GlaxoSmithKline 78
Not applicableStudy completedNCT04671446What this trial is testingIdentification of Autoantigens in EGPA and Severe Eosinophilic AsthmaWho this might be right forChurg-Strauss SyndromeEosinophilic AsthmaEosinophilic Esophagitis+1 more Queen Mary University of London 120
Large-scale testing (Phase 3)Study completedNCT01508936What this trial is testingStudy to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe AsthmaWho this might be right forEosinophilic Asthma Teva Branded Pharmaceutical Products R&D, Inc. 511
Post-approval studies (Phase 4)Enrolling By InvitationNCT07654842What this trial is testingFasenra: An Asthma StudyWho this might be right forEosinophilic AsthmaSevere AsthmaSevere Eosinophilic Asthma+1 more Endeavor Health 40
Large-scale testing (Phase 3)Active Not RecruitingNCT05692180What this trial is testingA Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic AsthmaWho this might be right forAsthma AstraZeneca 94
Large-scale testing (Phase 3)Looking for participantsNCT07671001What this trial is testingDepemokimab in Participants of 6 to 11 Years of AgeWho this might be right forAsthma GlaxoSmithKline 34